pharmaphorum

OCTOBER 7, 2022

IQVIA has the long term market data, from World Reviews back to 1978, to investigate, and analysed nearly 30 years of launches into leading therapy classes, from multiple eras in the development of the pharmaceutical industry. About the author. Is this true? The launches into these therapy areas happened from 1995 onwards.

Competition 73

Competition Marketing Medicine Pharmaceutical 73

European Pharmaceutical Review

DECEMBER 19, 2022

Although the joint-statement is said to be necessary owing to the “uncertainty among stakeholders on the use of biosimilars in clinical practice”, a 2021 report by IQVIA found that the volume of biosimilar prescribing across the European Economic Area generated €5.7 About the authors. EMA Biosimilars Q&A. Lausuntopalvelu.fi.

Medicine 52

Medicine Biopharma Safety Food 52

pharmaphorum

DECEMBER 13, 2022

If BYOD is used to capture copyrighted or validated questionnaires, it is advisable to engage with the copyright holders and authors early to identify any particular conditions for use if questionnaires are implemented in a BYOD solution. About the author. Prior to joining IQVIA in 2018, J.C.

Electronics 57

Electronics Insurance Patients Management 57

European Pharmaceutical Review

SEPTEMBER 2, 2022

An RMP is submitted as part of the dossier of all new drug applications and is evaluated by regulatory authorities before authorisation is given. Such as plan may also be requested by regulatory authorities for authorised products without one in place should concerns arise about a risk affecting the benefit-risk balance. References.

Food and Drug Administration 74

Food and Drug Administration Medicine Safety Food 74

pharmaphorum

SEPTEMBER 14, 2022

As will be discussed at the 2022 DPharm annual conference in Boston, IQVIA, a global clinical research organization, surveyed more than 6,400 participants across the U.S. About the author. Mark Brown, Vice President, Global Patient and Site Solutions, IQVIA.

Recruitment 88

Recruitment Patients Media Management 88

pharmaphorum

JUNE 30, 2022

At DIA, we presented findings from a 2021 global survey of patients and study investigators conducted by IQVIA, which showed that both groups are interested in decentralized trials (DCTs). About the Author. It’s vital we know what’s necessary to interest patients and sites in trial participation.

Patients 62

Patients Recruitment Transportation Healthcare 62

PM360

JULY 13, 2023

Launched in April 2023, BrightInsight’s PSP+ Companion App, built on the compliant BrightInsight Platform, connects patients to the resources they need to complete prior authorization, register for financial assistance, understand and track their therapies, and much more.

Education 89

Education Medical Media Patients 89

PM360

OCTOBER 25, 2023

The Enormous and Growing Economic Impact of the NP/PA Prescriber Today, NPs and PAs are authorized to prescribe in all 50 states and D.C. This article explores NPs/PAs and the opportunities available to engage them more fully as their role in our healthcare system continues to grow. NPs/PAs write approximately 1.4

Physicians 98

Physicians Marketing Medical Prescription 98

pharmaphorum

JANUARY 25, 2023

About the author Susan Hill joined IQVIA in 2018 as part of the acquisition of AHM and is responsible for the customer engagement and commercial compliance technology offerings.

Marketing 92

Marketing Sales Retail Management 92

pharmaphorum

JANUARY 27, 2023

About the author Marie E. Lamont is the global head of RWE Data Strategy, Access & Enablement at IQVIA and general manager at Inteliquet, a patient-matching clinical trial software company.

Physicians 98

Physicians Healthcare Healthcare Patients 98

pharmaphorum

DECEMBER 4, 2022

About the author. Katie currently leads offering development at IQVIA for the Human Data Science Cloud. As the tech industry continues to flourish, successful companies will take active steps to support women in their career goals, while providing them with female mentorship from above and upward mobility career opportunities.

Pharma 96

Pharma Management Education Leads 96

European Pharmaceutical Review

JULY 20, 2022

Real-world data was gathered from IQVIA Medical Research Data (IMRD) electronic health records (eHR) databases for France, Germany and the UK to find out how many patients were using each drug during the 12 months before and after regulatory action. About the author. tetrazepam – a muscle relaxant. Real-world data and results.

Medicine 78

Medicine Safety Side effects Electronics 78

PM360

APRIL 22, 2024

The opinions expressed by the authors in the Think Tank section are their own and do not necessarily reflect those of their affiliated companies or organizations CAMERON THOMPSON General Manager of AnswerSuite, a Syneos Health Company There are two shifts that have emerged in engaging physicians over the last few years.

Education 59

Education Physicians Healthcare Healthcare 59

pharmaphorum

OCTOBER 26, 2022

Working with IQVIA, they found that the cost for 8.4 About the author. As a result, society and government bodies have not developed models and policies that adequately support the development of and access to rare disease drugs.”. million rare disease patients in the U.S. is approximately $2.2 trillion per year.

Patients 77

Patients Pharma Consulting Transportation 77

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. About the author. The hard problem: innovation for high prevalence, chronic diseases of ageing. She holds a degree in biochemistry from Oxford University.

FDA 84

FDA Healthcare Healthcare Medicine 84

PM360

DECEMBER 20, 2023

market (source: IQVIA MIDAS, May 2023). Regulatory body – NMPA : all pharmaceutical products sold in the Chinese market need to be granted market authorization by NMPA. From 2017 to 2022, the Chinese market witnessed a growth rate of 5.3%, compared to the average market growth of 6.6% in the top five European Union markets and 7.1%

Marketing 105

Marketing Insurance Medical Manufacturing 105

pharmaphorum

JUNE 29, 2022

COVID vaccines and treatments have created a substantial market over and above the existing Rx market- IQVIA estimates that the cumulative value of COVID vaccines could be between $185 and 295bn to 2026. About the author. Sarah Rickwood, VP, EMEA Thought Leadership and Marketing, IQVIA. Orphan drugs launch challenges.

Doctors 57

Doctors Medicine Marketing Prescription 57

pharmaphorum

SEPTEMBER 30, 2022

The traceability of components is critical for authoring structured content correctly, especially when it comes to fulfilling compliance regulations. The largest barrier is the perception that all documents must first be broken down into components before using component-based authoring tools. About the author.

Management 52

Management Pharmaceutical Marketing Electronics 52

pharmaphorum

JANUARY 9, 2023

About the author. Sarah Rickwood has 30 years’ experience as a consultant to the pharmaceutical industry, having worked in Accenture’s pharmaceutical strategy practice prior to joining IQVIA. The next article in this three-part series will explore three of the areas of growth and opportunity for innovative healthcare companies.

Medicine 86

Medicine Healthcare Healthcare Pharma 86

PM360

AUGUST 9, 2022

According to a recent IQVIA analysis, only one in four patients who were new to a brand in 2021 successfully initiated therapy. “To Addressing the issue of medication adherence begins before a patient even fills their first prescription.

Food and Drug Administration 105

Food and Drug Administration Prescription Patients Medical 105

pharmaphorum

JANUARY 20, 2023

Indeed, IQVIA analysis has found that NICE-approved medicines can take four years to reach the expected uptake. About the author Leela Barham is a researcher and writer who has worked with all stakeholders across the health care system, both in the UK and internationally, on the economics of the pharmaceutical industry.

Medicine 93

Medicine Government Patients Management 93

pharmaphorum

OCTOBER 11, 2022

About the author. Dr. Gerd Rippin, Director Biostatistics at IQVIA, received his bachelor’s degree in Statistics in 1995 from the University of Dortmund, Germany, and his PhD in 1999 from the University of Mainz, Germany.

Medicine 88

Medicine Physicians Patients Safety 88

World of DTC Marketing

OCTOBER 28, 2021

Yet granting Medicare broad authority to intervene in setting prices has nonetheless divided the party. A separate report by the IQVIA Institute for Human Data Science found that patients paid a whopping record of $67 billion out of pocket for prescriptions filled in retail pharmacies in 2019.

Pharma 263

Pharma Prescription Retail Government 263